Aspira Women's Health Inc.
COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT

Last updated:

Abstract:

The present invention provides compositions and methods that provide a high degree of sensitivity and a high degree of specificity for the preoperative assessment of ovarian tumors in an African American subject (e.g., pre- and post-menopausal women) having a variety of ovarian cancer types (e.g., clear cell/mucinous, low malignant potential, high malignant potential) and at a variety of disease states (e.g., early and late stage).

Status:
Application
Type:

Utility

Filling date:

13 Aug 2019

Issue date:

15 Jul 2021